NDC 81033-150-20 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-150
- Requested NDC
- 81033-150-20
- Package NDCs from labels
- 81033-150-10, 81033-150-44, 81033-150-52, 81033-150-20, 81033-150-43
- Manufacturer
- Kesin Pharma Corporation
- Effective date
- 2025-09-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - Kesin Pharma Corporation | Kesin Pharma Corporation | 2025-09-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81033-150-10 | Megestrol Acetate | 10 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 10 | 2 | |
| 81033-150-20 | Megestrol Acetate | 20 mL in 1 CUP, UNIT-DOSE | SUSPENSION | 20 | 2 | |
| 81033-150-43 | Megestrol Acetate | 30 in 1 CARTON | SUSPENSION | 30 | 2 | |
| 81033-150-44 | Megestrol Acetate | 40 in 1 CARTON | SUSPENSION | 40 | 2 | |
| 81033-150-52 | Megestrol Acetate | 100 in 1 CASE | SUSPENSION | 100 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 81033-150-10 | ML - Milliliter | 81033-150 | 2543ec6f-320f-47bb-88e6-1bd5a4fa284b | 1 | 2025-10-14 |
| 81033-150-20 | ML - Milliliter | 81033-150 | 9e74f5d4-302f-4a2d-a129-9a357e7aca57 | 1 | 2025-10-14 |
| 81033-150-43 | ML - Milliliter | 81033-150 | 279d1fc3-9aa7-4b9b-937a-b401452542c0 | 1 | 2025-10-14 |
| 81033-150-44 | ML - Milliliter | 81033-150 | 9e40ce0b-f969-42d9-bcec-d288997ecd7a | 1 | 2025-10-14 |
| 81033-150-52 | ML - Milliliter | 81033-150 | 2736f854-8353-4dde-8304-cfebdc4cac39 | 1 | 2025-10-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services, LLC | 905bd658-a0af-4f20-be3d-00c54868a26c | 2026-01-29 | Warnings | F05Q2T2JA0 |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Stool Softener Laxative | DOCUSATE SODIUM | Meijer Distribution Inc. | 81edf0d8-b6f3-4b3a-85db-0108160756b1 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1ad73079-ebb3-dae7-e063-6294a90a0558 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | 1Q73Q2JULR |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| DOCUSATE SODIUM 100MG | DOCUSATE SODIUM 100MG | Farmacias De Similares TX LLC | 44269b79-a5ad-f443-e063-6294a90a8473 | 2026-01-28 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 19830f9a-27b1-910d-e063-6294a90adace | 2026-01-27 | Warnings | F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | Morepen Laboratories Limited | 3cf42333-7479-940a-e063-6394a90aedee | 2026-01-23 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 1f6c3b64-0fcd-4cd3-9947-453d79468292 | 2026-01-19 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | WALGREEN COMPANY | 21fbddce-d3e7-4090-9e69-f4e07fa97ba2 | 2026-01-19 | Warnings | F05Q2T2JA0 |
| SWISS BLEU Relief-Calm Antimicrobial Skin Cream | LACTOBACILLUS FERMENT LYSATE, LEONTOPODIUM ALPINUM, CALENDULA OFFICINALIS FLOWER EXTRACT, EVENING PRIMROSE FLOWER EXTRACT, CITRIC ACID | Nanjing Hongruixing Biological Technology Co., Ltd | 487d3c2c-ce28-f7a1-e063-6294a90a5ec6 | 2026-01-16 | Warnings | 2968PHW8QP |
| Lemon Glycerin | GLYCERIN | Jianerkang Medical Co., Ltd | edee14da-13d8-4bc2-9c37-cfc353763d11 | 2026-01-16 | Warnings | PDC6A3C0OX |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2026-01-15 | Warnings, Adverse reactions | 860225 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Natco Pharma USA LLC | 582cff8a-1def-43d6-ba7e-dce49e3e9f27 | 2026-01-15 | Warnings, Adverse reactions | ANDA075671 860225 TJ2M0FR8ES |
| Hemorrhoidal Cream | HEMORRHOIDAL CREAM | Walgreens | 1ac2b2ae-c090-483b-ad2c-1374552add4a | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | f19c6cca-e763-4c38-a546-855f027d20c5 | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | 1a00ff43-ba79-4339-a547-f9757872958b | 2026-01-15 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.